Revlimid 5 mg (Lenalidomide CAPSULE) 5 MG

REVLIMID 5 MG capsules are a prescription medication used to treat certain conditions. This oral treatment is manufactured by Bristol-Myers Squibb Canada and is available in a 100-capsule pack.

Strength

5 MG

Pack Size

100

Manufacturer / TM Owner

BRISTOL-MYERS SQUIBB CANADA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REVLIMID 5 MG capsules are primarily used in the management of specific hematological conditions. This medication is often prescribed to support the treatment of certain blood disorders. Patients may wonder, 'What is REVLIMID used for?' and it is typically utilized in conjunction with other therapies to address these conditions.

Side Effects

Common effects of REVLIMID 5 MG capsules may include fatigue, diarrhea, and constipation. Some users might experience muscle cramps or rash. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

REVLIMID 5 MG capsules should be handled with care, as they are intended for specific medical uses. Pregnant women should avoid handling this medication due to potential risks. Always follow the guidance of a healthcare professional when using this product.

Avoid Interactions

REVLIMID 5 MG capsules may interact with certain medications, including those that affect the immune system. Alcohol and other substances that suppress the immune response should be avoided. Patients should inform their healthcare provider about all medications they are taking to prevent potential interactions.

Frequently Asked Questions

REVLIMID is primarily used in the treatment of certain hematological conditions, often in combination with other therapies.

REVLIMID 5 MG capsules should be stored at room temperature, away from moisture and heat.

Common side effects may include fatigue, diarrhea, constipation, muscle cramps, and rash.

REVLIMID may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

REVLIMID is not recommended for pregnant women and should be handled with care to avoid exposure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.